Cardinal Health stock trades below its EUR 213.50 weekly high
Published on 10/10/2026 at 10:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- EUR 211.95 in weekend trading at Lang & Schwarz
- Weekly cited range: EUR 207.30 to EUR 213.50
- Cardinal Health reaffirmed fiscal 2027 adjusted EPS guidance
Cardinal Health stock was EUR 211.95 in weekend trading at Lang & Schwarz at 10:14 a.m. CEST on October 10, 2026, down EUR 0.15, or 0.07 percent, versus the EUR 212.10 close at Lang & Schwarz on October 9, 2026.
The week in figures
The weekend-trading reference price was EUR 211.95. The highest cited Lang & Schwarz level during the week was EUR 213.50, while the lowest was EUR 207.30. The reference price was EUR 0.15 below the EUR 212.10 close at Lang & Schwarz on October 9, 2026.
The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of Cardinal Health stock.
Chronology of the week
On October 7, Cardinal Health's fiscal 2027 non-GAAP EPS guidance was cited at USD 12.40 to USD 12.60. On October 9, the company's first-quarter fiscal 2027 results date was cited as November 5. Cardinal Health's October 1 press release states that the company entered into a binding letter of intent to extend its existing pharmaceutical distribution agreement with CVS Health through June 30, 2032.
The same release says Cardinal Health reaffirmed fiscal 2027 non-GAAP EPS growth guidance of 13 percent to 15 percent and long-term non-GAAP EPS growth guidance of 12 percent to 14 percent.
Market context: Market report S&P 500.
Dates of the coming week
The next Xetra session is scheduled for October 12, 2026. The next company date identified in the release is November 5, 2026, when Cardinal Health plans to report first-quarter fiscal 2027 results.
